Over the summer Merck, the White House Station, New Jersey-based drug maker, cut its sales force by 15%, or 1,200 reps. Now, as it looks to reconfigure its sales efforts, it will be going forward with a contract sales team in a deal with inVentiv Health, also from New Jersey.

After the mixed results of cholesterol drugs Vytorin and Zetia, Merck is ultimately finding a new way to bring its products to market.

inVentiv is a firm that offers drug and biotech companies a service package that includes sales, marketing, communications, and clinical trial management.

On Merck’s end, they are looking to essentially let the subcontracted work pay for itself, and not have to take on full-time recruits and the labor cost that comes with them. As the market fluctuates and new products roll out, the company is limiting its risk.

Merck’s sales strategy is set to go into effect by next year, and will run with a combination of the current in-house staff and the inVentiv contract team.

Click here to learn more about pharmaceutical jobs in your area.

Add To Favorites

Email To Friend

Back To Archives

Testimonial of the Week

I was facing the seven-year itch at my previous workplace. Thanks to EmploymentCrossing, I'm committed to a fantastic sales job in downtown Manhattan.

Joseph L New York, NY

+ Read More Testimonial

Only PharmaceuticalCrossing consolidates every job it can find in the domain and puts all of the job listings it locates in one place.

We have more jobs than any other job board.
We list jobs you will not find elsewhere that are hidden in small regional publications and employer websites
We collect jobs from more than 4,429,376 websites and post them on our site.
We are private, and therefore far fewer people are applying for the jobs on our site than are applying for those on public job boards.